These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 3856862)

  • 1. Cell lines and clinical isolates derived from Ph1-positive chronic myelogenous leukemia patients express c-abl proteins with a common structural alteration.
    Konopka JB; Watanabe SM; Singer JW; Collins SJ; Witte ON
    Proc Natl Acad Sci U S A; 1985 Mar; 82(6):1810-4. PubMed ID: 3856862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of P210bcr-abl tyrosine protein kinase activity in various subtypes of Philadelphia chromosome-positive cells from chronic myelogenous leukemia patients.
    Maxwell SA; Kurzrock R; Parsons SJ; Talpaz M; Gallick GE; Kloetzer WS; Arlinghaus RB; Kouttab NM; Keating MJ; Gutterman JU
    Cancer Res; 1987 Mar; 47(6):1731-9. PubMed ID: 2434223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variable expression of the translocated c-abl oncogene in Philadelphia-chromosome-positive B-lymphoid cell lines from chronic myelogenous leukemia patients.
    Konopka JB; Clark S; McLaughlin J; Nitta M; Kato Y; Strife A; Clarkson B; Witte ON
    Proc Natl Acad Sci U S A; 1986 Jun; 83(11):4049-52. PubMed ID: 3012546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphotyrosine antibodies identify the p210c-abl tyrosine kinase and proteins phosphorylated on tyrosine in human chronic myelogenous leukemia cells.
    Naldini L; Stacchini A; Cirillo DM; Aglietta M; Gavosto F; Comoglio PM
    Mol Cell Biol; 1986 May; 6(5):1803-11. PubMed ID: 2431286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unique forms of the abl tyrosine kinase distinguish Ph1-positive CML from Ph1-positive ALL.
    Clark SS; McLaughlin J; Crist WM; Champlin R; Witte ON
    Science; 1987 Jan; 235(4784):85-8. PubMed ID: 3541203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular cloning and serological characterization of an altered c-abl gene product produced in Ph1 CML patients.
    Mes-Masson AM; McLaughlin J; Witte O
    Haematol Blood Transfus; 1987; 31():163-6. PubMed ID: 3127280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of a translocated c-abl gene in hybrids of mouse fibroblasts and chronic myelogenous leukaemia cells.
    Kozbor D; Giallongo A; Sierzega ME; Konopka JB; Witte ON; Showe LC; Croce CM
    Nature; 1986 Jan 23-29; 319(6051):331-3. PubMed ID: 3455750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overlapping cDNA clones define the complete coding region for the P210c-abl gene product associated with chronic myelogenous leukemia cells containing the Philadelphia chromosome.
    Mes-Masson AM; McLaughlin J; Daley GQ; Paskind M; Witte ON
    Proc Natl Acad Sci U S A; 1986 Dec; 83(24):9768-72. PubMed ID: 3540951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The chronic myelogenous leukemia-specific P210 protein is the product of the bcr/abl hybrid gene.
    Ben-Neriah Y; Daley GQ; Mes-Masson AM; Witte ON; Baltimore D
    Science; 1986 Jul; 233(4760):212-4. PubMed ID: 3460176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breakpoints on chromosomes 9 and 22 in Philadelphia chromosome-positive chronic myelogenous leukemia (CML). Amplification of rearranged c-abl oncogenes in CML blast crisis.
    Collins SJ
    J Clin Invest; 1986 Nov; 78(5):1392-6. PubMed ID: 3021820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An 8-kilobase abl RNA transcript in chronic myelogenous leukemia.
    Gale RP; Canaani E
    Proc Natl Acad Sci U S A; 1984 Sep; 81(18):5648-52. PubMed ID: 6091099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of molecular variants of p210bcr-abl in chronic myelogenous leukemia.
    Kurzrock R; Kloetzer WS; Talpaz M; Blick M; Walters R; Arlinghaus RB; Gutterman JU
    Blood; 1987 Jul; 70(1):233-6. PubMed ID: 2885048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No correlation between locations of bcr breakpoints and clinical states in Ph1-positive CML patients.
    Ogawa H; Sugiyama H; Soma T; Masaoka T; Kishimoto S
    Leukemia; 1989 Jul; 3(7):492-6. PubMed ID: 2733454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-abl and bcr are rearranged in a Ph1-negative CML patient.
    Bartram CR; Kleihauer E; de Klein A; Grosveld G; Teyssier JR; Heisterkamp N; Groffen J
    EMBO J; 1985 Mar; 4(3):683-6. PubMed ID: 3859408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of herbimycin A and its derivatives on growth and differentiation of Ph1-positive acute lymphoid leukemia cell lines.
    Sato S; Honma Y; Hozumi M; Hayashi Y; Matsuo Y; Shibata K; Omura S; Hino K; Tomoyasu S; Tsuruoka N
    Leuk Res; 1994 Mar; 18(3):221-8. PubMed ID: 8139288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localization of the human c-sis oncogene in Ph1-positive and Ph1-negative chronic myelocytic leukemia by in situ hybridization.
    Bartram CR; de Klein A; Hagemeijer A; Grosveld G; Heisterkamp N; Groffen J
    Blood; 1984 Jan; 63(1):223-5. PubMed ID: 6336312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence of a new chimeric bcr/c-abl mRNA in patients with chronic myelocytic leukemia and the Philadelphia chromosome.
    Stam K; Heisterkamp N; Grosveld G; de Klein A; Verma RS; Coleman M; Dosik H; Groffen J
    N Engl J Med; 1985 Dec; 313(23):1429-33. PubMed ID: 3864009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the abl oncogene and its involvement in chromosomal translocations in human leukemia.
    Rosson D; Reddy EP
    Mutat Res; 1988 May; 195(3):231-43. PubMed ID: 3129652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular biology of chronic myelogenous leukemia.
    Dreazen O; Canaani E; Gale RP
    Semin Hematol; 1988 Jan; 25(1):35-48. PubMed ID: 3279514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular pathology of chronic myelogenous leukemia.
    Gorska-Flipot I; Norman C; Addy L; Minden M
    Tumour Biol; 1990; 11 Suppl 1():25-43. PubMed ID: 2247753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.